A long-term, open-label study of levodopa–/INS;carbidopa intestinal gel in advanced Parkinson's disease patients: safety and motor-symptom endpoints

2013 ◽  
Vol 333 ◽  
pp. e127 ◽  
Author(s):  
A.J. Espay ◽  
P. Odin ◽  
H.H. Fernandez ◽  
R.A. Hauser ◽  
D.G. Standaert ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Motor Symptom ◽  
Open Label ◽  
Advanced Parkinson’S Disease ◽  
Open Label Study ◽  
Label Study

scholarly journals Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results

2013 ◽  
Vol 19 (3) ◽  
pp. 339-345 ◽  
Author(s):  
Hubert H. Fernandez ◽  
Arvydas Vanagunas ◽  
Per Odin ◽  
Alberto J. Espay ◽  
Robert A. Hauser ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Open Label ◽  
Advanced Parkinson’S Disease ◽  
Open Label Study ◽  
Label Study

Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson's Disease

2011 ◽  
Vol 121 (5) ◽  
pp. 246-253 ◽  
Author(s):  
Robert A. Hauser ◽  
Heinz Reichmann ◽  
Mark Lew ◽  
Afsaneh Asgharian ◽  
Clare Makumi ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Prolonged Release ◽  
Open Label ◽  
Once Daily ◽  
Open Label Study ◽  
Label Study ◽  
Early Parkinson’S Disease

Risperidone in levodopa-induced psychosis in advanced parkinson's disease: An open-label, long-term study

1997 ◽  
Vol 12 (4) ◽  
pp. 610-612 ◽  
Author(s):  
Giuseppe Meco ◽  
Andrea Alessandri ◽  
Patrizia Giustini ◽  
Vincenzo Bonifati
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Open Label ◽  
Term Study ◽  
Advanced Parkinson’S Disease ◽  
Long Term Study
Sign in / Sign up

Export Citation Format

Share Document